Consumer Medicine Information - Medsafe
2 FLUCLOXACILLIN is available only with a doctor's prescription. Before you take FLUCLOXACILLIN WARNING: Flucloxacillin can cause severe liver damage, particularly in older
Tags:
Information
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document:
Documents from same domain
ADVANTAN Presentation Uses - Medsafe
www.medsafe.govt.nzADVANTAN® Data Sheet Page 1 of 9 ADVANTAN® Methylprednisolone aceponate 0.1% ointment/cream . Presentation 1 g cream or ointment contains 1 mg (0.1%) methylprednisolone aceponate.
Presentation, Advantan presentation uses, Advantan, Uses, Methylprednisolone aceponate, Methylprednisolone, Aceponate
LOXALATE 1. Product Name - Medsafe Home Page
www.medsafe.govt.nzPage 5of 21 at risk, such as the elderly, or patients with cirrhosis, or if used in combination with other medications which may cause hyponatraemia.
DATA SHEET 1 CLEXANE AND CLEXANE FORTE ... - …
www.medsafe.govt.nzNew Zealand Data Sheet June 2017 . clexane-clexane-forte-ccdsv13-dsv18-16jun17 Page 2 . 100 mg injection enoxaparin sodium 100mg (equivalent to …
SEPTANEST Articaine hydrochloride 4% with …
www.medsafe.govt.nzSEPTANEST Articaine hydrochloride 4% with adrenaline 1:100,000 Injection for local and regional dental anaesthesia DESCRIPTION SEPTANEST is a sterile aqueous solution that contains articaine hydrochloride 4% (40 mg/mL) with adrenaline acid tartrate in a 1:100,000 strength.
BOOSTRIX - Medsafe Home Page
www.medsafe.govt.nz1 BOOSTRIX®. Combined diphtheria, tetanus, acellular pertussis (dTpa) vaccine . CONSUMER MEDICINE INFORMATION WHAT IS IN THIS LEAFLET? This leaflet answers some of the common questions about BOOSTRIX vaccine.
NEW ZEALAND DATA SHEET - Medsafe
www.medsafe.govt.nzNEW ZEALAND DATA SHEET Cymevene ® DS 170831 2 of 26 Caution: Cymevene must only be administered by IV infusion over 1 hour, preferably via a
Edition Draft - Medsafe
www.medsafe.govt.nzPart 4, Ed Draft Page 2 of 9 Section 1: Good Manufacturing Practice Documentation 1.1. When is GMP Documentation Required? Medsafe requires evidence of Good Manufacturing Practice (GMP) compliance for
Draft, Good, Practices, Manufacturing, Edition, Edition draft, Good manufacturing practice
Data Sheet 1 PRODUCT NAME 2 QUALITATIVE AND …
www.medsafe.govt.nzNew Zealand Data Sheet 31 July 2017 Lantus – insulin glargine lantus-ccdsv19-dsv11-31jul17 Page 1 Data Sheet 1 PRODUCT NAME Lantus 100 IU/mL solution for injection in 10 …
NEW ZEALAND DATA SHEET MESTINON® - Medsafe
www.medsafe.govt.nzNEW ZEALAND DATA SHEET MESTINON® MESTINON Page 4 of 8 As the severity of myasthenia gravis often fluctuates considerably, particular care is required to
DATA SHEET PREDNISONE - Medsafe
www.medsafe.govt.nz• Epilepsy and/or seizure disorder • Peptic ulceration • Previous steroid myopathy • Tuberculosis • Patients with myasthenia gravis receiving anticholinesterase therapy since
Related documents
CP.FLU.JNT.C.V6P1 Flucloxacillin JNT Capsules PIL …
www.medicines.org.ukCP.FLU.JNT.C.V8P1 P217/16 Package leaflet: Information for the patient FLUCLOXACILLIN 250MG CAPSULES FLUCLOXACILLIN 500MG CAPSULES Flucloxacillin
NEW ZEALAND DATA SHEET 1. FLUCLOXACILLIN 2. …
www.medsafe.govt.nzPage 3 of 11 Flucloxacillin is contraindicated in patients with a previous history of flucloxacillin-associated jaundice/hepatic dysfunction.
AUSTRALIAN PRODUCT INFORMATION APO- …
www.medicines.org.au1 australian product information – apo- flucloxacillin (flucloxacillin sodium monohydrate) 1 name of the medicine flucloxacillin sodium monohydrate. 2 and 3 qualitative and quantitative composition and
PACKAGE LEAFLET: INFORMATION FOR THE USER …
www.medicines.org.ukPACKAGE LEAFLET: INFORMATION FOR THE USER Flucloxacillin 250mg Capsules BP Flucloxacillin 500mg Capsules BP (flucloxacillin sodium) Read all of this leaflet carefully before you start taking this medicine.
Capsule, Flucloxacillin, 250mg, Flucloxacillin 250mg capsules bp flucloxacillin, Capsules bp
Flucloxacillin 2g, powder for solution for injection or ...
www.mhra.gov.ukFlucloxacillin 2g, powder for solution for injection or infusion PL 31745/0032 2 LAY SUMMARY . Flucloxacillin 2g, powder for solution for injection or infusion
GUIDELINES ON THE MANAGEMENT OF CELLULITIS …
www.acutemed.co.ukcrestcrest clinical resource efficiency support team guidelines on the management of cellulitis in adults june 2005
Penicillin Allergy AUSG October 2005
www.nhstaysideadtc.scot.nhs.ukAll drug-allergies must be specified on medication charts (with the patient’s reaction) In TRUE penicillin allergy* ALL penicillins, cephalosporins and …
Consensus Document on the Management of …
www.lymphoedema.org1 Final Version Revised Cellulitis Guidelines December 2016 Consensus Document on the Management of Cellulitis in Lymphoedema Cellulitis is an acute spreading inflammation of the skin and subcutaneous tissues
Management, Document, Consensus, Consensus document on the management